Jing Li
University of California, San Francisco
ORCID: 0000-0002-3298-2112Also affiliated with Changchun University of Chinese Medicine, University of San Francisco
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Jing Li, Nick Bansback, Chien‐Wen Tseng, Steve Shiboski, Gabriela Schmajuk +2 more
Papers
Driven by 7 papers — median percentile 58. Top paper: “Patterns of Infliximab Biosimilar Uptake for Medicare, Medicaid, and Private Insurance from 2016 to 2022”.
Jing Li, Nick Bansback, Chien‐Wen Tseng, Steve Shiboski, Gabriela Schmajuk +2 more
Emma Kersey, Jing Li, Rahaf Baker, Christine Anastasiou, Andriko Palmowski +4 more
Rahaf Baker, Rachael Stovall, Jeffrey R. Curtis, Fenglong Xie, Jinoos Yazdany +2 more
Jing Li, Julia Adler‐Milstein, Jinoos Yazdany, Stephen Shiboski, Gabriela Schmajuk +1 more
Gabriela Schmajuk, Jing Li, Matthew Murrill, Jinoos Yazdany, Eric T. Roberts
Jing Li, Mehret Birru Talabi, Amanda M. Eudy, Gabriela Schmajuk, Megan E. B. Clowse
Jing Li, Michael Evans, Nevin Hammam, Patricia Katz, Alexis Ogdie +4 more